₹ 1,938.40
-21.30 (-1.09%)
I
IPCA Laboratories
₹ 1,938.40
IPCA Laboratories EPS Summary (consolidated)
The latest quarterly EPS of IPCA Laboratories as of Q2 Sep 2026 stands at ₹14.79. This is a 6.63% fall quarter on quarter and 32.76% growth same quarter last year. For the FY2026 the EPS of IPCA Laboratories stands at ₹44.98. This is a 54.68% growth compared with FY2025.
IPCA Laboratories EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

